NCT06383598 2026-04-07
PD-L1 Specific [68Ga]Ga-THP-PDL1-3 Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Phase NA Recruiting
Clinical Trials
11 trialsNCT06503146 2026-03-27
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
NCT05436093 2026-03-04
CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Phase NA Recruiting
NCT05844306 2025-11-19
RefleXion PET/CT Imaging Performance in Patients With Various Malignancies
City of Hope Medical Center
Phase NA Suspended
NCT06429891 2024-08-22
Research on Early Diagnosis and Clinical Transformation of Nuclide Probe Based on Bioorthogonal-gastric Cancer Mucin Target Visualization
Peking University Cancer Hospital & Institute
Phase NA Recruiting
NCT05322512 2023-11-29
Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Phase NA Unknown
NCT02717572 2019-04-05
18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR
Washington University School of Medicine
Phase 1 Completed
NCT02070406 2019-02-28
Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies
Jonsson Comprehensive Cancer Center
Phase 1 Terminated
NCT02599194 2019-01-03
18F-FSPG PET/CT for Cancer Patients on Therapy
Stanford University
Phase 2 Completed
NCT00019565 2016-09-26
PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00816335 2016-04-04
Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed